Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$4,119,862
-$4,428,756 QoQ
Shares Held
65,457
-46.3% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#70
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. TARS ranks #70 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in TARS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,119,862 65,457
2026-03-31 $8,548,618 121,862
2025-12-31 $9,680,590 118,229
2025-09-30 $10,961,862 184,450
2025-06-30 $4,146,967 102,369
2025-03-31 $7,778,496 151,421
2024-12-31 $8,496,027 153,441
2024-09-30 $2,603,769 79,166
2024-06-30 $434,608 15,990
2024-03-31 $418,715 11,519
2023-12-31 $223,782 11,051
2023-09-30 $200,641 11,291
2023-06-30 $168,159 9,306
2023-03-31 $144,227 11,474
2022-12-31 $109,788 7,489
2022-09-30 $126,123 7,367
2022-06-30 $125,151 8,572
2022-03-31 $79,490 4,726
2021-12-31 $127,957 5,687
2021-09-30 $116,735 5,417
2021-06-30 $161,533 5,574
2021-03-31 $126,857 3,936
2020-12-31 $178,297 4,314